Study of point-of-care hepatitis C testing in adults
Part of Digestive system, Infections clinical trials.
This study collects basic information from adults who already had a quick, on-site hepatitis C (HCV) test. It aims to improve how point-of-care testing is done and documented, which may lead to faster follow-up and care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- You must have already received a point-of-care hepatitis C (HCV) test
- No other specific medical requirements were listed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies point-of-care (on-site) testing to find hepatitis C in adults who are at higher risk. If hepatitis C is found, earlier detection can help you get connected to care sooner.
This study is setting up a program to test adults for hepatitis C antibodies using quick, point-of-care tests. It helps confirm how well this testing approach works in real-world care so more people can be identified and treated earlier.
This study looks at what patients think about and are willing to use a quick “point-of-care” blood test for hepatitis C virus (HCV) after a positive antibody screen. It may help the ER find people with possible active infection faster and improve how testing is offered.
This trial tests a home-use test for hepatitis C (HCV) to see if people can use it correctly without help. It is for adults who are not healthcare workers or in other studies.
This study compares two ways to treat hepatitis C: getting treatment at a local clinic near you, or the usual care at a central hospital. It aims to see if treatment at local clinics is safe, effective, and more convenient for patients.
This study aims to make hepatitis C treatment simpler and more accessible for people who inject drugs. If you join, you'll receive care that fits your lifestyle and helps cure hep C.
Hear when a new Hepatitis C trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.